IRIS
COMOLLI, GIUDITTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.115
AS - Asia 896
EU - Europa 709
SA - Sud America 126
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.897
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.075
CN - Cina 274
SG - Singapore 240
IT - Italia 173
VN - Vietnam 145
HK - Hong Kong 114
RU - Federazione Russa 112
IE - Irlanda 105
BR - Brasile 87
DE - Germania 85
FI - Finlandia 60
FR - Francia 40
GB - Regno Unito 34
ZA - Sudafrica 34
IN - India 26
SE - Svezia 18
IQ - Iraq 17
PL - Polonia 17
MX - Messico 16
CA - Canada 15
BE - Belgio 11
JP - Giappone 11
VE - Venezuela 11
ES - Italia 10
UA - Ucraina 10
BD - Bangladesh 9
PH - Filippine 9
ID - Indonesia 8
NL - Olanda 8
AR - Argentina 7
TR - Turchia 7
AT - Austria 6
CL - Cile 4
CO - Colombia 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
LT - Lituania 4
MA - Marocco 4
PY - Paraguay 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
BH - Bahrain 3
AL - Albania 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
JM - Giamaica 2
JO - Giordania 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
NP - Nepal 2
PE - Perù 2
PK - Pakistan 2
TN - Tunisia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
LV - Lettonia 1
MN - Mongolia 1
MU - Mauritius 1
MZ - Mozambico 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TM - Turkmenistan 1
Totale 2.897
Salva come PNG Salva come JPEG
Città #
Dallas 177
Singapore 156
Ashburn 123
San Jose 120
Hong Kong 113
Dublin 101
Beijing 81
Chandler 77
New York 58
Ho Chi Minh City 48
Munich 48
Milan 43
Los Angeles 37
Helsinki 36
Pavia 34
Boardman 30
Hanoi 29
Johannesburg 29
Lauterbourg 28
Ann Arbor 26
Shanghai 24
Moscow 18
Nanjing 18
Turku 18
Redondo Beach 17
Princeton 16
Jacksonville 14
Orem 14
Lawrence 13
Wilmington 13
Buffalo 12
Santa Clara 12
Warsaw 12
Frankfurt am Main 11
Rome 11
Seattle 11
Tokyo 11
Medford 10
Poplar 10
Brooklyn 9
Biên Hòa 8
Brussels 8
Chennai 8
Denver 8
Shenyang 8
São Paulo 8
The Dalles 8
Toronto 8
Council Bluffs 7
Da Nang 7
Hebei 7
Mexico City 7
Nanchang 7
Stockholm 7
Baghdad 6
Amsterdam 5
Düsseldorf 5
London 5
San Francisco 5
Columbus 4
Corsico 4
Falls Church 4
Jinan 4
Piscataway 4
Pune 4
Vũng Tàu 4
Atlanta 3
Belo Horizonte 3
Boston 3
Cascina 3
Changsha 3
Charlotte 3
Guangzhou 3
Ha Long 3
Haiphong 3
Hamad Town 3
Hangzhou 3
Houston 3
Hải Dương 3
Jiaxing 3
Montreal 3
Mumbai 3
Nha Trang 3
Tashkent 3
Tianjin 3
Vigevano 3
Washington 3
Amman 2
Annapolis 2
Bereguardo 2
Bogotá 2
Brescia 2
Buccinasco 2
Bulungan 2
Bắc Giang 2
Bắc Ninh 2
Bến Tre 2
Cairo 2
Cao Lanh 2
Caracas 2
Totale 1.917
Salva come PNG Salva come JPEG
Nome #
Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation 157
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 148
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 146
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 131
Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. 130
Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells 126
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 125
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 118
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 113
Occult HIV infection in a large sample of health-care users in Lombardy, Italy in 2014-2015: Implications for control strategies 108
Human Cytomegalovirus-Specific Memory CD4+T-Cell Response and Its Correlation with Virus Transmission to the Fetus in Pregnant Women with Primary Infection 104
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers 100
Dengue Virus-Specific Humoral and T Cellular Immune Response in Italian Residents and Travelers Returning from Endemic Areas 100
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study 94
Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation. 93
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy 92
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 91
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 90
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 89
Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay 85
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 81
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 81
The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy 80
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay 76
Human Cytomegalovirus and Epstein-Barr virus specific immunity in patients with ulcerative colitis 75
Performance of new pp65-IGRA for the quantification of HCMV-specific CD4+ T-cell response in healthy subjects and in solid organ transplant recipients 75
Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up 66
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 65
Memory T cells specific for HBV enumerated by a peptide-based cultured enzyme-linked immunospot assay in healthy HBV-vaccinated subjects 49
Different Antigen-Specific CD4+ and CD8+ T-Cell Response against HCMV Proteins in Pregnant Women with Primary Infection and in Control Subjects with Remote Infection 42
Totale 2.930
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.331
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 4 6 1
2021/202294 3 2 2 2 4 4 7 8 1 12 9 40
2022/2023284 17 27 2 18 12 19 0 7 120 2 55 5
2023/2024258 24 34 11 9 13 82 26 17 1 8 17 16
2024/2025620 17 34 9 45 13 47 32 22 152 39 74 136
2025/20261.496 104 113 209 185 185 83 317 91 134 75 0 0
Totale 2.930